Skip to content
value.today

Guided Therapeutics Inc.

Total raised
$3 M
1 round on record
Latest round
$3 M
Aug 2010
First round on record
Aug 2010
Today
Went public
See the company page

Guided Therapeutics Inc. is listed today as Guided Therapeutics Inc.: market value, financials and filings are on its company page.

Funding rounds

1 counted as startup funding, 3 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Guided Therapeutics Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2015$3 MPrivate placement after listing$2 to $10 million

Guided Therapeutics Inc.: Private sale, Jun 2015

Investors in this round

1 investor had bought by the notice of Jul 15, 2015: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 3 investors are named for Guided Therapeutics Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$3 M of $5 M offered; $3 M still to sell
Smallest investment taken
$25,000
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
$1 million to $5 million
Sales commissions
$360,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Gene S. Cartwright · Executive Officer, Director
  • Rick M. Fowler · Executive Officer · VP Engineering
  • John E. Imhoff · Director
  • Johnathan M. Niloff · Director
  • Linda M. Rosenstock · Director
  • Michael C. James · Director
  • Ronald W. Hart · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Ladenburg Thalmann & Co. Inc. (CRD 505) · New York, New YorkSold in AR, FL, GA, MA, NY, OK

Remarks in the notice

  • On fees: “Also reimbursed for out of pocket and legal expenses.”
  • On the amounts: “$4,000,000 of $5,277,000 will be cash proceeds; remainder to be exchanged securities.”

Signed by Gene S. Cartwright, President & CEO. Source: SEC Form D, newest notice filed Jul 15, 2015. Read the notice at the SEC.

equity, optionsSEC
Apr 2014$3 MPrivate placement after listing$2 to $10 million

Guided Therapeutics Inc.: Private sale, Apr 2014

Investors in this round

1 investor had bought by the notice of May 13, 2014: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 3 investors are named for Guided Therapeutics Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
$1,000,000
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
$1 million to $5 million
Sales commissions
none
Finders' fees
none
Paid to its own people
$3,000,000 (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Gene S. Cartwright · Executive Officer, Director
  • John E. Imhoff · Director
  • Jonathan M. Niloff · Director
  • Linda M. Rosenstock · Director
  • Mark L. Faupel · Director
  • Michael C. James · Director
  • Ronald W. Hart · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The offering is closed.”

Signed by Gene S. Cartwright, President & CEO. Source: SEC Form D, newest notice filed May 13, 2014. Read the notice at the SEC.

debt, optionsSEC
May 2013$3 MPrivate placement after listing$2 to $10 million

Guided Therapeutics Inc.: Private sale, May 2013

Investors in this round

11 investors had bought by the notice of Jun 3, 2013: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 3 investors are named for Guided Therapeutics Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$3 M of $3 M offered; $0 M still to sell
Smallest investment taken
$25,000
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
$1 million to $5 million
Sales commissions
$151,619
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Mark L Faupel · Executive Officer, Director
  • Richard L Fowler · Executive Officer
  • John E Imhoff · Director
  • Jonothan M Niloff · Director
  • Linda M Rosenstock · Director
  • Michael C James · Director
  • Ronald W Allen · Director
  • Ronald W Hart · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • SunTrust Robinson Humphrey, Inc. (CRD 6271) · Atlanta, GeorgiaSold in AR, CA, GA, IL, KY, MA, NY, OK

Remarks in the notice

  • On fees: “Also reimbursed for out of pocket and legal expenses.”
  • On the amounts: “The offering is closed.”

Signed by Mark L. Faupel, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 3, 2013. Read the notice at the SEC.

equity, optionsSEC
Aug 2010$3 MNo. 1$2 to $10 million

Guided Therapeutics Inc.: Raise no. 1, Aug 2010

Investors in this round

3 investors had bought by the notice of Sep 13, 2010: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 3 investors are named for Guided Therapeutics Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$3 M of $5 M offered; $2 M still to sell
Smallest investment taken
$50,000
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Mark L Faupel · Executive Officer, Director
  • Richard L. Fowler · Executive Officer
  • Shabbir L. Bambot · Executive Officer
  • John E Imhoff · Director
  • Jonathan M Niloff · Director
  • Michael C James · Director
  • Ronald W Allen · Director
  • Ronald W Hart · Director
  • William E Zachary · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mark L. Faupel, President, CEO and Acting CFO and Director. Source: SEC Form D, newest notice filed Sep 13, 2010. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Guided Therapeutics Inc. had revenue between $1 million and $5 million when it filed its newest notice of a funding round (Jul 2015).

    SEC Form D (revenue range) · Jul 2015

  • Revenue range over time, as stated in its notices: revenue of up to $1 million in 2010; revenue between $1 million and $5 million in 2013; revenue between $1 million and $5 million in 2014; revenue between $1 million and $5 million in 2015.

    SEC Form D (revenue range) · Jul 2015

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jul 2015

Products and services#

No products or services of Guided Therapeutics Inc. are on record.

Investors#

3 named in official filings. Open an investor to see everything it has backed.

Investors in Guided Therapeutics Inc.
InvestorKindAmountRoundRoleSource
Alan GrujicPersonnot statednot statedHeld Series E preferred stock, director (Form 3, 2023)SEC Form 3
John E. ImhoffPersonnot statednot statedHeld Series A preferred stock, 10% owner, director (Form 3, 2011)SEC Form 3
Lynne H. ImhoffPersonnot statednot statedHeld Series C-1 preferred stock, 10% owner (Form 3, 2018)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 3 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Guided Therapeutics Inc.
NameRoleNamed in
Gene S. CartwrightExecutive officerJul 2015
Rick M. FowlerVP EngineeringJul 2015
Mark L FaupelExecutive officerJun 2013
Richard L FowlerExecutive officerJun 2013
Richard L. FowlerExecutive officerSep 2010
Shabbir L. BambotExecutive officerSep 2010
Gene S. CartwrightDirectorJul 2015
John E. ImhoffDirectorJul 2015
Johnathan M. NiloffDirectorJul 2015
Linda M. RosenstockDirectorJul 2015
Michael C. JamesDirectorJul 2015
Ronald W. HartDirectorJul 2015
Jonathan M. NiloffDirectorMay 2014
Mark L. FaupelDirectorMay 2014
John E ImhoffDirectorJun 2013
Jonothan M NiloffDirectorJun 2013
Linda M RosenstockDirectorJun 2013
Mark L FaupelDirectorJun 2013
Michael C JamesDirectorJun 2013
Ronald W AllenDirectorJun 2013
Ronald W HartDirectorJun 2013
Jonathan M NiloffDirectorSep 2010
William E ZacharyDirectorSep 2010

Went public since 2012. Its SEC number is that of a company listed on a stock exchange.